FACIT
Overview
Trusted by 80+ organisations across 14 countries, we deliver cutting-edge AI for video redaction and powerful analytics, backed by 2 pioneering technology patents. Headquartered in Milton Keynes, our …
Investment Focus
- Focus on oncology innovations
- Alignment with Ontario's biotech ecosystem
- Potential for commercialization and market impact
- Commitment to patient benefit and economic growth
Portfolio Companies
Reach FACIT directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about FACIT
What sectors does FACIT invest in?
FACIT invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Research, and is based in Knowlhill, Milton Keynes, United Kingdom. FACIT is listed as a venture capital in the ConnectSafely investor database.
What stage does FACIT invest at?
FACIT backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO.
Which regions does FACIT invest in?
FACIT invests across Canada.
What companies has FACIT invested in?
FACIT's portfolio includes Turnstone Biologics, HDAX Therapeutics, cTRL Therapeutics, Fusion Pharmaceuticals, Hyivy Health, Radiant Biotherapeutics and Nanology Labs.
How do I contact FACIT?
FACIT's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
